Charles River Laboratories International, Inc. (CRL) Stock Grade

About Charles River Laboratories International, Inc.'s fundamentals

Charles River Laboratories is a $10.1 billion healthcare company in medical diagnostics and research that reported a net loss in its latest annual statement, resulting in a negative net margin of -3.6% and no dividend. Revenue declined 0.9% year-over-year, indicating flat-to-declining top-line performance in the current period. Despite the accounting losses, the company generated positive free cash flow, suggesting it converted some operational activity into actual cash despite its reported net loss.